Prostate cancer biology, genetics, and the new therapeutics
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Language: | English |
| Edition: | Second edition. |
| Subjects: | |
| Online Access: | Link to e-book |
| Physical Description: | xxi, 508 pages : illustrations (some color) ; 27 cm |
| Bibliography: | Includes bibliographical references and index. |
| Published: |
Totowa, N.J. :
Humana Press,
[2007]
|
| ISBN: | 9781597452243 1597452246 |
Table of Contents:
- Xenograft models of human prostate cancer
- The pathology of human prostatic atrophy and inflammation
- Tissue microarrays in prostate cancer research
- Prostate (cancer) stem cells
- Cancer-host interactions: a paradigm shift brings new understanding and new opportunities
- Androgen receptor function in prostate cancer progression
- Hedgehog signaling in development and cancer
- Cholesterol, cell signaling, and prostate cancer
- Gene therapy for advanced prostate cancer
- Role of transforming growth factor-€ in immunotherapy of prostate cancer
- Biology and therapeutic basis of prostate cancer bone metastasis
- Molecular imaging: noninvasive strategies to visualize gene expression in living subjects
- Quantum dot nanotechnology for prostate cancer research
- Expression profiling of prostate cancer progression
- Somatic alterations in prostate cancer progression
- Linkage studies of prostate cancer families to identify susceptibility genes
- Somatic DNA methylation changes and prostatic carcinogenesis
- Telomeres, telomerase, chromosome stability, and prostate cancer
- Racial differences in prostate cancer mortality
- Radiotherapy for the treatment of locally advanced prostate cancer
- Recombinant antibody candidates for treatment of prostate cancer
- Differentiation agents and epigenomic therapies: an overview and potential use for prostate cancer
- Taxane-based chemotherapy for prostate cancer
- Co-targeting therapeutics for hormone refractory prostate cancer
- Intercellular targets of prostate cancer
- Novel and efficient translational clinical trial designs in advanced prostate cancer.